Trilogy International is forecasting a 13% increase in revenue for its 2014 financial year following the company's move to rebrand itself and its products.
The skincare and candle company, formerly known as Ecoya, told shareholders at its annual meeting on Tuesday it was forecasting revenue of $30 million for the 12 months to March 2014, compared with $26.6 million in 2013.
The company had changed its name, and also the packaging of its Trilogy skincare range, and Trilogy International chief executive Stephen Sinclair said it had made big changes to its Ecoya products.
"This time last year (we) extended our product range and that investment in product and change of product has been really good for our sales, and people interacting with the brand, so we are moving towards profit," Mr Sinclair said.
"We've got a manufacturing facility in Sydney that's got a lot of capacity and the sales that we're driving are helping to fill that capacity and move us towards profitability."
However, it remained reliant on Trilogy to underpin the company's earnings.
Trilogy's performance in the "home markets" of New Zealand and Australia was strong, with distribution in about 2500 retail outlets, Mr Sinclair said.
It was also expanding in Britain and Japan, and had opportunities in Hong Kong and Singapore, he said.